WEBINAR LaunchBio's Designed for Success
Date and Time
Thursday Apr 23, 2020
1:00 PM - 1:45 PM EDT
April 23
1:00 - 1:45 p.m.
Location
Webinar
Fees/Admission
Register here.
Website
WEBINAR LaunchBio's Designed for Succ...
Description
Early-Phase Study Design for Biotech
At what point in the process should a biotech business think about clinical trial study designs that will carry their idea through FDA approvals? When and how should they retain the services of a CRO to help them along? Join us for a conversation with one CRO, Celerion, and one of their clients, Bryn Pharma.
Speakers:
- Caroline Engel, BSc, Senior Scientist II, Protocol Design & Dev., Clinical Pharmacology, Celerion
- David A. Dworaczyk, PhD, Chief Executive Officer, Bryn Pharma, LLC
